rs1064792923
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_StrongPP5_Moderate
The NM_000548.5(TSC2):c.5281_5296delTCCAACCCCAGCCTAC(p.Ser1761LeufsTer60) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. S1761S) has been classified as Likely benign.
Frequency
Consequence
NM_000548.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant polycystic kidney diseaseInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- polycystic kidney disease 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- autosomal recessive polycystic kidney diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Caroli diseaseInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TSC2 | NM_000548.5 | c.5281_5296delTCCAACCCCAGCCTAC | p.Ser1761LeufsTer60 | frameshift_variant | Exon 42 of 42 | ENST00000219476.9 | NP_000539.2 | |
| PKD1 | NM_001009944.3 | c.*1251_*1266delTGGGGTTGGAGTAGGC | downstream_gene_variant | ENST00000262304.9 | NP_001009944.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TSC2 | ENST00000219476.9 | c.5281_5296delTCCAACCCCAGCCTAC | p.Ser1761LeufsTer60 | frameshift_variant | Exon 42 of 42 | 5 | NM_000548.5 | ENSP00000219476.3 | ||
| PKD1 | ENST00000262304.9 | c.*1251_*1266delTGGGGTTGGAGTAGGC | downstream_gene_variant | 1 | NM_001009944.3 | ENSP00000262304.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Tuberous sclerosis 2 Pathogenic:1
This sequence change deletes 16 nucleotides in exon 42 of the TSC2 mRNA (c.5281_5296delTCCAACCCCAGCCTAC), causing a frameshift at codon 1761. This creates a premature translational stop signal in the last exon of the TSC2 mRNA (p.Ser1761Leufs*60). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 47 amino acids of the TSC2 protein. This variant has been reported in an individual with tuberous sclerosis complex (TSC) in the Leiden Open-source Variation Database (PMID: 21520333, 25498131). Multiple frameshift variants including c.5340_5371del (p.1784Alafs*?) and c.5405_5408dup (p.Phe1803Leufs*42), located downstream of this variant have been reported as disease-causing de novo variants in individuals affected with TSC (PMID: 10205261, 9328481, 24789117), suggesting that frameshift variants affecting the very C-terminal of TSC2 impact protein function and cause disease. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at